Kendra Peltier
Nurse Practitioner · Lewisburg, WVNPI 1619548559
Payments from drug & device makers
Across 136 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$752
- Lilly USA, LLC$220
- Dexcom, Inc.$154
- Insulet Corporation$136
- Bayer$126
- Boehringer Ingelheim$112
- plus $559 from 14 others
What the payments were for
- Food & beverage$2,059100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $752 |
| Lilly USA, LLC | 14 | $220 |
| Dexcom, Inc. | 8 | $154 |
| Insulet Corporation | 8 | $136 |
| Bayer | 7 | $126 |
| Boehringer Ingelheim | 6 | $112 |
| AbbVie | 6 | $107 |
| Abbott | 5 | $85 |
| Xeris Pharmaceuticals, Inc. | 5 | $82 |
| AstraZeneca | 4 | $62 |
| Tandem Diabetes Care, Inc. | 3 | $52 |
| Amgen | 2 | $35 |
| Cequr Corporation | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
| Averitas Pharma Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $18 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
How this compares
$2,059 in reported general payments places this provider in the 85th percentile of 649 nurse practitioner providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 163 | $232,888 |
| OzempicSemaglutide | 65 | $109,749 |
| TrulicityDulaglutide | 56 | $92,720 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 35 | $82,079 |
| JardianceEmpagliflozin | 47 | $69,921 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $65,530 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 35 | $48,233 |
| FarxigaDapagliflozin Propanediol | 35 | $34,484 |
| Tresiba Flextouch U-100Insulin Degludec | 38 | $27,875 |
| Humulin R U-500Insulin Regular, Human | 15 | $25,891 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $21,221 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 88 | $14,916 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $14,285 |
| Novolog FlexpenInsulin Aspart | 48 | $12,988 |
| NovologInsulin Aspart | 21 | $8,897 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $220 | $325,608219 claims |
| Novo NordiskOzempic, Novolog | $752 | $118,64686 claims |
| Boehringer IngelheimJardiance | $112 | $69,92147 claims |
| AstraZenecaFarxiga | $62 | $34,48435 claims |
| AbbVieSynthroid, Armour Thyroid | $107 | $4,31949 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Lewisburg
- Leigh BrooksPrinceton$75K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
- Lacy HowardWheeling$18K
- Robin BlumeBeckley$18K
- Kellie VaughtBeckley$17K
- Lisa WalkerBeckley$17K
- Rachel BrillSouth Charleston$16K
- Kelly HughartSouth Charleston$13K
- Amy HaughtSouth Charleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.